(Q46109460)

English

Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group

scientific article published in January 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

object named as

Olav Dahl

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

2

object named as

Øystein Fluge

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

6

object named as

Barthold Vonen

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

Norwegian Gastrointestinal Cancer Group

12

object named as

Norwegian Gastrointestinal Cancer Group

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

author name string

Erik Carlsen

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

Johan N Wiig

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

Helge E Myrvold

5

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

Nina Podhorny

7

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

Ottar Bjerkeset

8

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

Tor Jack Eide

9

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

Tore B Halvorsen

10

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

Kjell Magne Tveit

11

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

publication date

1 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

Acta Oncologica

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

48

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

368-376

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

Adjuvant therapy for colon and rectal cancer. NIH Consensus Development Conference

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Adjuvant therapy of colorectal cancer. Why we still don't know

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Adjuvant therapy for stage II colon cancer: an elephant in the living room?

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

An overview of adjuvant therapy for colorectal cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer.

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Effective surgical adjuvant therapy for high-risk rectal carcinoma

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Adjuvant management of rectal cancer: the more we learn, the less we know

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Current options for the management of rectal cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of rectal cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Preoperative versus postoperative chemoradiotherapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Chemotherapy with preoperative radiotherapy in rectal cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Canc

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Is it deleterious to delay the start of adjuvant chemotherapy in colon cancer stage III?

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1.

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

The microsatellite instability phenotype in human colorectal carcinoma: relationship to sex, age, and tumor site

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06.

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Capecitabine as adjuvant treatment for stage III colon cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Sex differences in colorectal cancer mortality in Europe, 1955–1996

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Colorectal cancer survival trends in Norway 1958–1997

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Identifiers

10.1080/02841860902755244

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46109460&oldid=2119344919"